Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305835 · ClinicalTrials.gov registry record
Monogenic Kidney Stone - Genetic Testing
A clinical trial of Rare Kidney Stone Diseases, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 6,000
- Enrollment target
- 1
- Study location
NCT03305835 is a study of Rare Kidney Stone Diseases that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 6,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03305835, a study of Rare Kidney Stone Diseases, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 6,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. This information may help develop more effective treatments for monogenic kidney stone diseases.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305835
The ClinicalTrials.gov registry entry for NCT03305835 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rare Kidney Stone Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT03305835 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03305835 about?
NCT03305835 is a clinical study titled "Monogenic Kidney Stone - Genetic Testing". This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. Th...
What is the current status of trial NCT03305835?
This trial is currently recruiting. The enrollment target is 6,000 participants. The study started on 2017-09-11. Estimated completion is 2028-02.
What conditions does trial NCT03305835 study?
This clinical trial studies the following conditions: Rare Kidney Stone Diseases.
Who is sponsoring clinical trial NCT03305835?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03305835 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.